Abstract:OBJECTIVE:To investigate the relationship between G1958A gene polymorphism of methylenetetrahydrofolate dehydrogenase (MTHFD) and occurrence of congenital heart disease (CHD) in North China.METHODS:One hundred and ninety-two CHD patients and their parents were included in this study as case group in Liaoning Province by birth defect registration cards, and 124 healthy subjects (age and gender matched) and their parents were simultaneously selected from the same geographic area as control. Their gene polymorphism of MTHFD G1958A locus was examined with PCR-RFLP, and serum folic acid and homocysteine (Hcy) levels were tested with radio-immunoassay and fluorescence polarization immunoassay (FPIA).RESULTS:There existed gene polymorphism at MTHFD G1958A locus in healthy subjects living in North China. The percentages of GG, GA, and AA genotype were 57.98%, 35.57%, and 6.45% respectively, and the A allele frequency was 24.23%, which was significantly different from Western population. No difference was observed when comparing genotype distribution and allele frequency between the case and control groups, so was the result from the comparison between genders. The A allele frequency of arterial septal defect patients' mothers (10.87%) was significantly lower than that of controls (28.15%) (P=0.014), with OR=0.31 (95% CI: 0.09-0.84), and no difference in the other subgroups. The percentage of at least one parent carrying A allele in arterial septal defect subgroup (43.48%) was significantly lower than that in controls (69.64%) (P=0.017), with OR=0.34 (95% CI: 0.12-0.92). The analysis of genetic transmission indicated that there was no transmission disequillibrium in CHD nuclear families. Their serum folic acid level was significantly higher than that of controls (P=0.000), and Hcy level of the former was higher than that of the latter with no statistical significance (P>0.05). Serum Hcy and folic acid levels of mothers with gene mutation were lower than those of mothers with no mutation.CONCLUSION:No significant difference of genotype distribution and allele frequency existed between CHD patients and healthy population. MTHFD G1958A mutation in parents (particularly in mother) can decrease the risk of arterial septal defect in offspring. The possible mechanism of protection might be mutation, which can increase MTHFD enzyme activity, folic acid metabolism and homocysteine remethylation, and decrease Hcy level.

Effect of parental 5, 10-methylenetetrahydrofolate dehydrogenase genotypes on offspring congenital heart defect risk

Mthfr C677t Polymorphism And Risk Of Congenital Heart Defects: Evidence From 29 Case-Control And Tdt Studies

Methylenetetrahydrofolate Dehydrogenase G1958A Gene Polymorphism and Congenital Heart Defect Susceptibility

Relationship Between Polymorphism of Methylenetetrahydrofolate Dehydrogenase and Congenital Heart Defect.

Association of fetal congenital heart diseases with methylenetetrahydrofolate reductase gene polymorphisms

Association of Maternal Folate Intake and Offspring MTHFD1 and MTHFD2 Genes with Congenital Heart Disease

Association between MTHFD1 G1958A polymorphism and neural tube defects susceptibility: a meta-analysis.

Parental Genetic Variants, Mthfr 677c>t and Mtrr 66a>g, Associated Differently with Fetal Congenital Heart Defect

[Effects of Methionine Synthase Gene Variation in Parents on Occurence of Congenital Heart Disease in Offspring].

[Study of serum Hcy and polymorphisms of Hcy metabolic enzymes in 192 families affected by congenital heart disease].

Maternal and Offspring Mthfr Gene C677t Polymorphism As Predictors of Congenital Atrial Septal Defect and Patent Ductus Arteriosus

Relationship of Maternal and Child Polymorphism in Methionine Synthetase and Methionine Synthase Reductase with Congenital Heart Disease

Association Between the Polymorphism of Methylenetetrahydrofolate Reductase Gene C 677 T and Risks of Congenital Heart Disease : Meta-analysis of Case-control Study

Meta-analysis of the Association Between 5,10-Methylenetetrahydrofolate Reductase C677T Polymorphisms and Congenital Heart Disease

Association of methylenetetrahydrofolate reductase gene polymorphisms and maternal folic acid use with the risk of congenital heart disease

Association of maternal methionine synthase reductase gene polymorphisms with the risk of congenital heart disease in offspring: a hospital-based case-control study

MTHFD1 polymorphism as maternal risk for neural tube defects: a meta-analysis

Polymorphism of Methionine Synthase Gene in Nuclear Families of Congenital Heart Disease

Relationship between methylenetetrahydrofolate dehydrogenase G1958A polymorphism and the susceptibility to neural tube defects: a meta-analysis

Meta Analysis of the Association Between MTHFR C677T Polymorphism and the Risk of Congenital Heart Defects.

PC82 STUDY ON SERUM HCY LEVEL AND HCY METABOLISM-RELATED ENZYMES POLYMORPHISMS IN NUCLEAR FAMILIES OF PATIENTS WITH CONGENITAL HEART DISEASE